[{"Assets_0_Q1_USD":609474000.0,"CommonStockSharesOutstanding_0_Q1_shares":122311917.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-44309000.0,"NetIncomeLoss_1_Q1_USD":-108071000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":122281000.0,"StockholdersEquity_0_Q1_USD":131943000.0,"EarningsPerShareBasic_1_Q1_USD":-0.88,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190515"}]